General Electric Company (BCBA:GE)

Verve Therapeutics Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	386,638,958	186,111,807	112,306,809	16,216,528	10,648,668	7,955,471
Market Cap Growth	106.11%	65.72%	592.54%	52.29%	33.85%	36.32%
Enterprise Value	398,405,018	192,018,406	117,056,641	19,404,937	15,432,734	13,227,830
Last Close Price	46125.00	24912.90	15471.33	2298.54	1576.21	997.47
PE Ratio	41.83	27.53	15.12	1795.19	-	18.68
PS Ratio	7.80	4.66	3.93	3.14	1.84	1.25
PB Ratio	16.77	9.23	4.86	2.62	2.49	2.55
P/TBV Ratio	56.01	27.57	10.06	6.28	21.64	269.54
P/FCF Ratio	-	49.08	32.10	17.42	43.79	47.57
P/OCF Ratio	-	38.33	26.77	15.47	29.79	26.52
EV/Sales Ratio	7.12	4.81	4.10	3.76	2.66	2.07
EV/EBITDA Ratio	26.96	20.83	19.50	21.21	65.63	55.55
EV/EBIT Ratio	31.75	24.01	23.18	27.52	-	-
EV/FCF Ratio	60.87	50.64	33.46	20.85	63.46	79.09
Debt / Equity Ratio	1.03	1.04	0.76	0.75	0.91	2.11
Debt / EBITDA Ratio	1.85	2.16	2.74	4.59	11.97	19.49
Debt / FCF Ratio	3.64	5.54	5.03	4.98	16.06	39.26
Asset Turnover	0.34	0.26	0.20	0.15	0.25	0.29
Inventory Turnover	2.49	2.69	1.98	1.23	2.71	3.46
Quick Ratio	0.68	0.77	1.01	0.82	0.93	1.20
Current Ratio	1.04	1.09	1.33	1.18	1.28	1.55
Return on Equity (ROE)	39.57%	27.64%	29.75%	3.53%	-12.55%	19.29%
Return on Assets (ROA)	4.61%	3.27%	2.16%	1.28%	-0.02%	-0.15%
Return on Capital (ROIC)	14.49%	10.74%	7.00%	3.54%	-0.04%	-0.33%
Return on Capital Employed (ROCE)	10.30%	8.70%	4.40%	2.90%	-	-
Earnings Yield	2.39%	3.63%	6.83%	0.37%	-6.11%	6.03%
FCF Yield	1.69%	2.04%	3.12%	5.74%	2.28%	2.10%
Dividend Yield	0.25%	4.63%	1.67%	2.47%	2.08%	2.70%
Payout Ratio	16.78%	15.38%	6.21%	190.18%	-	11.36%
Buyback Yield / Dilution	1.77%	0.46%	0.18%	-0.27%	-0.27%	-0.37%
Total Shareholder Return	2.02%	5.09%	1.85%	2.19%	1.81%	2.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.